New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE

Szűcs, ZsoltOstorházi, EszterKicsák, MátéNagy, LajosBorbás, AnikóHerczegh, Pál2019-09-172019-09-172019Journal Of Antibiotics. -72 : 7 (2019), p. 524-534. -J. Antibiot. - 0021-88200021-8820http://hdl.handle.net/2437/273572New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VREfolyóiratcikkopen access post-printhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM080877TermészettudományokKémiai tudományokhttp://www.nature.com/articles/s41429-019-0164-1Springer Naturehttp://dx.doi.org/10.1038/s41429-019-0164-162020-07-0200047306450000385063048179